A total of 14 products were added during the month, from eight different asset managers: Deerpath Capital, Echiquier, Eurizon, Franklin Templeton, Invesco, JP Morgan, Reverence Capital Partners. and UBAM.
CCR Monthly Approval Report – June 2026
July 6, 2026 by
In June, Allianz, BlackRock, Bluebay, Fidelity, First Trust, GAM, I Squared Capital, Morgan Stanley and Xtrackers were the fund sponsors gaining approval for new products.
CCR Monthly Approval Report – May 2026
June 9, 2026 by
A total of 11 products were added in the month from five different asset managers: Artemis, Columbia, Five Arrows, L Catterton and Xtrackers.
CCR Monthly Approval Report – April 2026
May 11, 2026 by
A total of six products were added in the month from six different asset managers: Aegon, Blackstone, DWS, Patria, Spruceview and Vontobel.
CCR Monthly Approval Report – March 2026
April 10, 2026 by
A total of seven products were added in the month from: Allianz, AltamarCAM Partners, Franklin Templeton, LS Power Equity Advisors, PIMCO and Vanguard.
CCR Monthly Approval Report – February 2026
March 9, 2026 by
A total of 19 products were added in the month from 12 different asset managers: ACRE Advisors, Amundi, Archimed, Bice, BlackRock, Eastspring, Invesco, iShares, MGG Investment Group, Stellex Capital, Stone Harbor and VanEck.
CCR Monthly Approval Report – January 2026
February 6, 2026 by
Sponsors gaining approval were Amundi, Azimut, Blue Owl Capital, Echiquier, Eurazeo, Invesco, iShares, Leonard Green and M&G.
CCR Monthly Approval Report – December 2025
January 7, 2026 by
Bradesco, HSBC, Invesco, VanEck, Wisdomtree, Lone Star Funds and TPG Angelo Gordon were the fund sponsors gaining approval for new product.
CCR Monthly Approval Report – November 2025
December 5, 2025 by
Alpheon, Danske, DPAM, Fidelity, Global X, iShares, Sixth Street, T. Rowe Price and Wellington were the fund sponsors gaining approval for new products in November.
CCR Monthly Approval Report – October 2025
November 11, 2025 by
Xtrackers got 37 of its ETFs registered in the month, while UBS had one equity mutual fund approved.
